US 9624228
Inhibitors of ERK and methods of use
granted A61KA61K31/4439A61K31/4745
Quick answer
US patent 9624228 (Inhibitors of ERK and methods of use) held by Kura Oncology, Inc. expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kura Oncology, Inc.
- Grant date
- Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/4439, A61K31/4745, A61K31/513, A61K31/5377